Tracy M. Downs
220 works · 4,681 citations · h-index 39
Top works
- Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
- Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
- Two-Dimensional Transcriptome Profiling: Identification of Messenger RNA Isoform Signatures in Prostate Cancer from Archived Paraffin-Embedded Cancer Specimens
- Racial/Ethnic and Gender Disparities in Renal Cell Carcinoma Incidence and Survival
- IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy.
- Health Related Quality of Life Patterns in Patients Treated With Interstitial Prostate Brachytherapy for Localized Prostate Cancer—Data From CaPSURE
- NCCN Guidelines Insights: Bladder Cancer, Version 5.2018
- WATCHFUL WAITING AND HEALTH RELATED QUALITY OF LIFE FOR PATIENTS WITH LOCALIZED PROSTATE CANCER: DATA FROM CaPSURE
- IFN-α 2B Enhances Th1 Cytokine Responses in Bladder Cancer Patients Receiving Mycobacterium bovis Bacillus Calmette-Guerin Immunotherapy
- Intravesical rAd–IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin–Refractory or Relapsed Non–Muscle-Invasive Bladder Cancer: A Phase II Randomized Study
- Profiling alternatively spliced mRNA isoforms for prostate cancer classification
- Is Ethnicity an Independent Predictor of Prostate Cancer Recurrence After Radical Prostatectomy?
- Expression signatures that correlated with Gleason score and relapse in prostate cancer
- Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?
- Penile Injection with Silicone: Case Report and Review of the Literature
- Feasibility and efficacy of neoadjuvant sunitinib before nephron‐sparing surgery
- Development and multi‐institutional validation of an upgrading risk tool for Gleason 6 prostate cancer
- Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA
- Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial
- The Selective Use of Dimercaptosuccinic Acid Renal Scans in Children with Vesicoureteral Reflux